# Myeloablative Busulfan/Melphalan Consolidation following Induction Chemotherapy for Patients with Newly Diagnosed High-Risk Neuroblastoma: Children's Oncology Group Trial ANBL12P1

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/myeloablative-busulfan-melphalan-consolidation-following-induction-chemotherapy/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Meaghan Granger,Arlene Naranjo,Rochelle Bagatell,Steven G. DuBois,Jeannine S. McCune,Sheena C. Tenney,Brian Weiss,Yaël P. Mossé,Shahab Asgharzadeh,Stephen Grupp,Michael D. Hogarty,Julie M. Gastier‐Foster,Denise Mills,Barry L. Shulkin,Marguerite T. Parisi,Wendy B. London,John Han-Chang,Joseph Panoff,Daniel von Allmen,Jason A. Jarzembowski,Julie R. Park,Gregory A. Yanik |
| Citations | 33 |
| DOI | 10.1016/j.jtct.2021.03.006 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://www.sciencedirect.com/science/article/pii/S2666636721007491/pdf |
| OpenAlex ID | https://openalex.org/W3134469664 |
| PMID | 33823167 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Joseph Panoff](https://scholariq.org/researchers/joseph-panoff/)

## Paper primary topic

- [Neuroblastoma Research and Treatments](https://scholariq.org/topics/neuroblastoma-research-and-treatments/)

## Paper topics

- [Neuroblastoma Research and Treatments](https://scholariq.org/topics/neuroblastoma-research-and-treatments/)
- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)
- [Cancer therapeutics and mechanisms](https://scholariq.org/topics/cancer-therapeutics-and-mechanisms/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.